George Woody, Perelman School of Medicine
1322 7. nóvember, 201740 ára afmælisráðstefna SÁÁ: International research on addiction treatment George Woody MD, Professor, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania Abstract The HIV epidemic generated a high level of interest in addiction research, particularly treatment research, due to it association with injecting drug use, and drug use and unprotected sex. The result …Read more »
Valgerður Rúnarsdóttir, Medical Director at SÁÁ
1317 8. nóvember, 201740 ára afmælisráðstefna SÁÁ: Opioid addiction in Iceland SÁÁ Valgerður Rúnarsdóttir, MD, Medical Director at SÁÁ Abstract In Iceland, the opioid addiction problem is because of prescription opioid almost solely. Heroin is not generally found on the black market but prescription tablets are. Prescription drugs are part of the addiction problem in general, like in other …Read more »
Kári Stefánsson, forstjóri Íslenskrar erfðagreiningar
1314 3. nóvember, 2017Erindi Kára Stefánssonar, forstjóra Íslenskrar erfðagreiningar, á málþinginu Fíkn og pólitík.
Arndís Sue Ching Löve, PhD student MS Pharm
1297 8. nóvember, 201740 ára afmælisráðstefna SÁÁ: Estimation of community drug abuse in the Reykjavík metropolitan area by wastewater analysis Arndís Sue Ching Löve, PhD student MS Pharm Abstract Introduction: Drug abuse has been a matter of concern worldwide due to the risks these substances pose to human health, and their connection to crime. Sewage epidemiology is a methodology used …Read more »
Nora D. Volkow, Director of the NIDA
1285 31. október, 201740 ára afmælisráðstefna SÁÁ Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a disease of the human brain. As a research psychiatrist and scientist, Dr. Volkow pioneered the …Read more »
Nora D. Volkow, Director of NIDA
1280 8. nóvember, 201740 ára afmælisráðstefna SÁÁ: Cannabis and society – can science guide public policies? Nora Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. Dr. …Read more »
Kári Stefánsson, CEO Decode Genetics
1272 24. október, 2017Kári Stefánsson, M.D., Dr. Med. has served as President, Chief Executive Officer and a Director since he founded deCODE genetics in August 1996. Dr. Stefánsson was appointed the Chairman of the Board of Directors of deCODE genetics in December 1999. From 1993 until April 1997, Dr. Stefánsson was a professor of Neurology, Neuropathology and Neuroscience …Read more »
Gregory Bunt, MD, FISAM
1250 8. nóvember, 201740 ára afmælisráðstefna SÁÁ: Medicinal Marijuana, Policy and Physician Gregory Bunt, MD FISAM, President, International Society of Addiction Medicine Diplomate, American Board of Psychiatry and Neurology, Clinical Assistant Professor of Psychiatry, NYU School of Medicine, New York, NY Dr. Gregory Bunt graduated medical school in 1983 from NYU School of Medicine, and completed his residency in Psychiatry …Read more »
Þórólfur Guðnason, Chief Epidemiologist
1244 8. nóvember, 2017Seminar: Viral infections and addiction, HIV and Hepatitis C Chair – Þórólfur Guðnason MD, PhD, Chief Epidemiologist, Centre for Health Security and Communicable Disease Control, Directorate of Health
Efni
- 2. okt. – Fjögur málþing (17)
- Fíkn og afbrot (4)
- Fíkn og konur (5)
- Fíkn og pólitík (4)
- Fíkn og stofnanir (4)
- 3. okt. – Fyrirlestrar (15)
- Cannabis (4)
- 4. okt. – Fyrirlestrar (16)
- Viðtöl (11)